GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Lupin Ltd

Lupin Appoints Brian Savage as President, Chief Legal Officer

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Oct 2026, 09:59 AM IST  ·  BSE ID: 1f4389e1-43b0-4644-9cce-83e9384a87b9
View Original BSE Filing (PDF)
💡
In Simple Terms
Pharma company Lupin Limited has hired a new Chief Legal Officer, Brian Savage, who previously worked at Teva Pharmaceuticals.
🤖 AI Summary
  • Lupin Limited appoints Brian Savage as President, Chief Legal Officer.
  • Savage will lead global Legal, Compliance, and IPMG functions.
  • He joins from Teva Pharmaceuticals, where he held senior legal roles.
  • Savage brings experience in the pharmaceutical legal and regulatory landscape.
  • He will be based in New Jersey.
🏢 How This Affects the Company
📈
Business Impact
The appointment of an experienced Chief Legal Officer is intended to strengthen the company's global legal and compliance functions, potentially impacting strategic decision-making and risk management in its pharmaceutical operations.
💰
Financial Impact
No direct financial impact is disclosed in this filing. Compensation details for the new appointee are not provided.
⚙️
Operational Impact
Brian Savage will lead Lupin’s global Legal, Compliance, and Intellectual Property Management Group functions, indicating a shift in operational oversight for these departments.
⚠️
Risk Impact
The appointment of an experienced legal professional with a background in navigating complex pharmaceutical regulatory environments is intended to enhance the company's risk mitigation strategies.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this management appointment.
👤
Who Is Affected
All shareholders are indirectly affected by changes in senior management that influence corporate governance and strategy.
🔍
Management Signal
The appointment signals management's focus on reinforcing its global legal and compliance framework.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future company announcements on legal strategy updates.
Performance of legal and compliance functions under new leadership.
Disclosure of any compensation details for the new officer.
LOW RISK Routine senior management appointment with no immediate financial implications.
💡 Investor Takeaway
Lupin Limited has appointed Brian Savage as President, Chief Legal Officer, who brings significant legal and regulatory experience from Teva Pharmaceuticals.
❓ Frequently Asked Questions
Who has Lupin Limited appointed as President, Chief Legal Officer?
Lupin Limited has appointed Brian Savage as President, Chief Legal Officer.
What is Brian Savage's previous role?
Brian Savage previously held senior leadership roles at Teva Pharmaceuticals, most recently serving as Executive Vice President and Interim Global Chief Legal Officer.
Where will Brian Savage be based?
Brian Savage will be based in New Jersey.
What functions will Brian Savage lead at Lupin?
He will lead Lupin’s global Legal, Compliance, and Intellectual Property Management Group (IPMG) functions.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.